CLINICAL_TRIALS trial_result · 2023-08-14

Clinical Trial Update: SPI-1005 for the Treatment of Patients With Meniere's Disease [Phase 2]

Phase 2 clinical trial update for SPI-1005 in patients with Meniere's disease; study completed with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Sound Pharmaceuticals, Incorporated | Conditions: Meniere's Disease | Phase 2 | Status: COMPLETED | Results posted: 2023-08-14